Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
D000293:Adolescent; D001859:Bone Neoplasms / Q000188:drug therapy*; D002648:Child; D002945:Cisplatin / Q000627:therapeutic use* / Q000633:toxicity; D004064:Digestive System / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D007668:Kidney / Q000187:drug effects; D008274:Magnesium / Q000097:blood; D008297:Male; D012516:Osteosarcoma / Q000188:drug therapy*; D012075:Remission, Spontaneous
D008274:Magnesium; D002945:Cisplatin